Recent Update:
Agents that target
disease pathways
Antibodies (monoclonal)
such as
Rituxan
Balancing
therapy-related
risks and benefits
Biologics Interferon, Neupogen, Leukine ...
Tips on
subcutaneous
injections
Bone
marrow (stem cell) transplants TIPS
Allogeneic: Mini /
Autologous /
Cord blood
Auto versus Allo SCT |
Donor
Lymphocyte Infusions (DLI)
HLA-typing and
Background
Harvesting / Mobilizing
stem cells
Graft vs Host Disease |
Patient
stories
Resources
Chimeric Antigen Receptor T-cells (CAR T-cells)
Chemotherapy
Alphabetical
index of agents
Agents grouped by mechanism
CHOP chemotherapy
Common chemo protocols (APO...VBM)
Liposomal (encapsulated) types
Low dose (metronomic) chemotherapy
PEP-C
Outcome abstracts -
Frontline
Treatment support for chemotherapy
Clinical
Trials
Focus on Clinical Trials
Find by Type of Lymphoma & Treatment Status
What's New - Trials
of Interest
By Type of Agent
New Trials
Complementary and
Alternative Medicine
Elderly
patients - treatment protocols and resources
Evaluating
medical claims recognizing bias; limits of abstracts, what makes information credible.
Graft vs Host Disease
Immune-based
therapies
Programming T-cells
MDS
(Myelodysplastic Syndrome)
Nanotechnology
Ofatumumab for CLL /
follicular lymphoma
Photopheresis
Pipeline
new agents with links to clinical trials
Pregnancy
During Lymphoma Treatment
Progress Review
Group (PRG) research objectives
Quality
of life
PAL: Providing
support and evidence-based information, independent of health
industry funding
|
Radio-immunotherapy
Bexxar
... centers
Zevalin ...
centers
Comparing Bexxar/Zevalin
RIT for bulky disease?
for Other Lymphoma Subtypes
and Indications
Radiofrequency
Ablation (RFA)?
Radiotherapy
Side
effects |
Treatment
support for
Refractory
lymphomas
protocols for lymphomas resistant to standard therapies
Protocols
|
Clinical
Trials
Remissions &
Response background & terms
Also
Spontaneous
regressions
Rituxan
- Basics ...
Side
effects ...
Check list what to expect,
bring, do.
Abstracts
| Maintenance
Side
effects common to treatments
Splenectomy
Stem cell Transplant
Surgery
for Lymphoma? (a common question)
Treatments
& Decisions
Goals
| Types |
Outcomes |
Interventions
PROTOCOL TYPES:
Standard
Off-label
... etc.
BEST PRACTICE GUIDELINES
(Standard of Care):
NCCN.org
PDF (login req.)
NCI Cancer.gov
 Treatment
decisions - factors that can influence treatment goal, type, and timing
and
Considerations
at relapse
Experts
on treatment
Treatment
outcome abstracts
Treatment Support
Treatment Timing?
Time
to Progression comparing protocols for first line treatment
of indolent NHL |
Frontline
Treatment
settings frontline, relapse, survival
Watchful
Waiting
Transformation
background and treatment
Vaccines
investigational patient-specific therapeutic vaccines
Categorized
abstracts |
Outcome
Data
What's
a Drug?
|
.gif){kind=small}